BiotechTube
Home/Kiora Pharmaceuticals/Stefan Sperl, PhD
SS

Stefan Sperl, PhD

Executive Vice President of CMC and Operations

Kiora Pharmaceuticals

Therapeutic Areas

OphthalmologyRetinal Diseases

Kiora Pharmaceuticals Pipeline

DrugIndicationPhase
KIO-301Retinitis Pigmentosa (Mutation Agnostic)Phase 1b
KIO-104Retinal InflammationPhase 2

Leadership Team at Kiora Pharmaceuticals

BM
Brian M. Strem, PhD
President & Chief Executive Officer
EJ
Eric J. Daniels, MD, MBA
Chief Development Officer
MT
Melissa Tosca, CPA
Chief Financial Officer
View full Kiora Pharmaceuticals profile